Functional food for preventing and treating cardiovascular and cerebrovascular diseases and preparation method thereof
A technology for cardiovascular and cerebrovascular diseases and functional foods, which is applied in the field of functional foods for the prevention and treatment of cardiovascular and cerebrovascular diseases and its preparation. The effect of cardiovascular and cerebrovascular diseases
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0025] Embodiment 1: Formula and preparation of functional food for preventing and treating cardiovascular and cerebrovascular diseases
[0026] A functional food formula for preventing and treating cardiovascular and cerebrovascular diseases, the formula components and proportions are: nattokinase 10%-20%, nitric oxide 10%-20%, coenzyme 10 5%-10%, red yeast rice extract 30%-50%, ginkgo biloba extract 20%-25%.
[0027] Coenzyme Q used in the present invention 10 Purchased from Xi'an Jinlv Biotechnology Co., Ltd., with a content of 98%; nattokinase was purchased from Beijing Nabain Food Co., Ltd.; nitric oxide was purchased from American Excellence Nutrition Company.
[0028] Preparation of the present invention comprises the following steps:
[0029] (1) Preparation of Red Yeast Extract:
[0030] Weigh a certain amount of red yeast rice powder → reflux extraction with 8 times the amount of 70%-80% ethanol for 3 times, each time for 2 hours → combine the extracts, remove the e...
Embodiment 2
[0037] Embodiment 2: toxicity test
[0038] According to "Food Safety Toxicological Evaluation Procedures and Methods" GB15193-2003, the food safety toxicology evaluation is carried out on the food of the present invention.
[0039] experiment method:
[0040] 1. Acute toxicity test: using the maximum tolerance test, select 20 Kunming mice with a body weight of 18-22g, half female, 25g functional food for preventing and treating cardiovascular and cerebrovascular diseases, add distilled water to 60mL (up to the maximum volume of mice for intragastric administration) Concentration), gavage twice a day, cumulative dose 25g / kg·bw, observe continuously for two weeks after gavage, record poisoning performance and death situation. The observation results showed no obvious symptoms of poisoning, and no death occurred during the 14-day observation period. After the observation period, the gross anatomy of the liver, kidney, lung, spleen and other organs of the mice was observed, and ...
Embodiment 3
[0057] Embodiment 3: Crowd observation experiment
[0058] (1), Experimental object:
[0059] The experimental group was divided into three age groups: 50-60 years old, 60-70 years old, and 70-80 years old. Each group selected 30 patients with cardiovascular and cerebrovascular diseases such as hypertension, hyperlipidemia, coronary heart disease, and atherosclerosis. The experimental group selected 30 people who also suffered from cardiovascular and cerebrovascular diseases, had similar conditions, and had similar living environment, level, and habits as the control group. Before the start of the experiment, blood pressure, blood lipid (total cholesterol, triglyceride, high-density lipoprotein, low-density lipoprotein), electrocardiogram and other signs were checked for the experimental group and the control group.
[0060] (2) How to take it:
[0061] The functional food prepared according to the above-mentioned functional food formula for preventing and treating cardiovas...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com